Pharmaceutical Executive, September 2022 Issue (PDF)
Articles in this issue
ESG: Applying Lessons From Consumer Market
21st Annual Industry Audit: Pharma Performance Check
DE&I in Pharma Sales & Marketing: ‘While There’s Work, There’s Promise’
The Manufacturing Edge on Path to Market
How Good is a Good Product Launch?
Assessing HCP-Visit Fallout: COVID’s Ultimate Impact on New Drug Entrants
More Than a Name: Vyvgart
Fighting Vision Loss: Vabysmo
A Sleeping Giant?: Quviviq
Next-level Efficacy: Mounjaro
LDL Game Changer: Leqvio
Bright Beginnings: Pharm Exec Profiles Five Recent Drug Launches
Building a New Legacy
The Biotech Rally Continues—What’s Fueling the Surge?
Are Tighter Health System Policies for Sales Reps Looming?
Recent Videos
Related Content
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Podcast
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
